By Del Quentin Wilber
Washington Post Staff Writer
Friday, January 16, 2009 11:50 AM
Roger Clemens' former personal trainer arrived at the U.S. Attorney's Office Friday for a day-long meeting with prosecutors to discuss allegations that the former pitcher used performance-enhancing drugs.
Brian McNamee, who has alleged he injected Clemens with human growth hormone (HGH) and steroids nearly 40 times, declined to comment as he entered the building in Northwest Washington. He was accompanied by two attorneys. One of those lawyers, Richard Emery, said he expected the meeting to last all day. He declined to comment further.
Clemens is under investigation by a federal grand jury on allegations that he lied to Congress last year when he told a committee on Feb. 13 that he had "never taken steroids or HGH."
He testified that the that he thought he was receiving injections of vitamin B12 and the painkiller lidocaine. At that same hearing before the House Committee on Oversight and Government Reform, McNamee testified that he injected Clemens with steroids and human growth hormones "at his direction."
Their testimony before Congress came two months after the release of a 311-page report by a Major League Baseball panel headed by former senator George J. Mitchell. The report, which relied on statements from McNamee, alleged that the star pitcher took steroids and HGH while playing for the Toronto Blue Jays and the Yankees.
McNamee's meeting with prosecutors this morning is just the latest sign that authorities have stepped up their investigation of Clemens. They were asked to investigate Clemens' testimony by the committee's chairman Rep. Henry A. Waxman (D-Calif.) and then-ranking minority member Rep. Tom Davis (R-Va.) two weeks after their hearing on the matter.
On Thursday, Kirk Radomski, the former New York Mets clubhouse attendant who supplied McNamee with the drugs, appeared before the grand jury in the District investigating the allegations. Prosecutors with the U.S. Attorney's Office in the District, which is overseeing the investigation, declined to comment.